Search research articles
Contact Us
Filters
Showing results (201-210 of 299) with videos related to
Page
of 30
Sort By:
Lancet (London, England)
|
October 6, 2014
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Frederick J Raal, Narimon Honarpour, Dirk J Blom, et al.
Neurobiology of Disease
|
June 11, 2025
Early and widespread cerebellar engagement during hippocampal seizures and interictal discharges
M L Streng, B W Kottke, E M Wasserman, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Early and widespread cerebellar engagement during hippocampal seizures and interictal discharges
M L Streng, B W Kottke, E M Wasserman, et al.
Journal of Traumatic Stress
|
April 2, 2020
Parental Wartime Deployment and Socioemotional Adjustment in Early Childhood: The Critical Role of Military Parents' Perceived Threat During Deployment
Nastassia J Hajal, Hilary J Aralis, Cara J Kiff, et al.
Circulation
|
December 13, 2016
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism
Gerald F Watts, Dick C Chan, Ricardo Dent, et al.
Diabetes Research and Clinical Practice
|
May 24, 2024
Text messaging to enhance glucose monitoring and self-care in teens with type 1 diabetes: Teens' perceptions predict outcomes
Charlotte W Chen, Emily Serata, Rachel Scheub, et al.
Cardiovascular Drugs and Therapy
|
March 4, 2016
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
Leslie Cho, Michael Rocco, David Colquhoun, et al.
Clinical Cardiology
|
August 19, 2018
Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies
Erik Stroes, Jennifer G Robinson, Frederick J Raal, et al.
Clinical Cardiology
|
January 31, 2014
Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy
Leslie Cho, Michael Rocco, David Colquhoun, et al.
Medical Hypotheses
|
November 1, 1995
Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus
Y Klipper-Aurbach, M Wasserman, N Braunspiegel-Weintrob, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 299) with videos related to
Sort By:
Page
of 30
Lancet (London, England)
|
October 6, 2014
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Frederick J Raal, Narimon Honarpour, Dirk J Blom, et al.
Neurobiology of Disease
|
June 11, 2025
Early and widespread cerebellar engagement during hippocampal seizures and interictal discharges
M L Streng, B W Kottke, E M Wasserman, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Early and widespread cerebellar engagement during hippocampal seizures and interictal discharges
M L Streng, B W Kottke, E M Wasserman, et al.
Journal of Traumatic Stress
|
April 2, 2020
Parental Wartime Deployment and Socioemotional Adjustment in Early Childhood: The Critical Role of Military Parents' Perceived Threat During Deployment
Nastassia J Hajal, Hilary J Aralis, Cara J Kiff, et al.
Circulation
|
December 13, 2016
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism
Gerald F Watts, Dick C Chan, Ricardo Dent, et al.
Diabetes Research and Clinical Practice
|
May 24, 2024
Text messaging to enhance glucose monitoring and self-care in teens with type 1 diabetes: Teens' perceptions predict outcomes
Charlotte W Chen, Emily Serata, Rachel Scheub, et al.
Cardiovascular Drugs and Therapy
|
March 4, 2016
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
Leslie Cho, Michael Rocco, David Colquhoun, et al.
Clinical Cardiology
|
August 19, 2018
Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies
Erik Stroes, Jennifer G Robinson, Frederick J Raal, et al.
Clinical Cardiology
|
January 31, 2014
Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy
Leslie Cho, Michael Rocco, David Colquhoun, et al.
Medical Hypotheses
|
November 1, 1995
Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus
Y Klipper-Aurbach, M Wasserman, N Braunspiegel-Weintrob, et al.
Page
of 30